• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Mechanical thrombectomy in acute ischemic stroke: Upper-Silesian Medical Center in Katowice experiences based on the treatment of the first 500 patients
Kardiol Pol. 2023 Mar 16. doi: 10.33963/KP.a2023.0071. Online ahead of print.NO ABSTRACTPMID:36929304 | DOI:10.33963/KP.a2023.0071
Source: Polish Heart Journal - March 17, 2023 Category: Cardiology Authors: Katarzyna Wilkosz-Musia ł Andrzej Kulach Grzegorz Smolka Wojciech Wojakowski Anetta Lasek-Bal Wac ław Kuczmik Rados ław Parma Krystian Wita Source Type: research

Response to the letter concerning the article "Rivaroxaban in secondary cardiogenic stroke prevention: two-year single-centre experience based on follow-up of 209 patients".
PMID: 27197013 [PubMed - indexed for MEDLINE]
Source: Kardiologia Polska - December 29, 2016 Category: Cardiology Authors: Lasek-Bal A, Urbanek T, Puz P, Piekarski M Tags: Kardiol Pol Source Type: research

CHA2DS2-VASC-AF2 score accurately predicts moderate-to-severe acute neurological dysfunction in the course of first ever ischemic stroke
Stroke remains one of the leading causes of death and serious long-term disability worldwide [1]. Cardio-embolic stroke, most frequently related to atrial fibrillation (AF), is associated with a high risk of severe psychomotor disability and high stroke-related mortality rate [2]. The commonly applied CHA2DS2-VASC score properly identifies patients at a very low risk of stroke who do not require long-term anticoagulation [3]. Apart from its high predictive value in terms of stroke risk stratification, pre-admission CHA2DS2-VASC score has been recently shown to reflect the actual severity of stroke, once it occurs [4 –5].
Source: International Journal of Cardiology - November 11, 2016 Category: Cardiology Authors: Maciej T. Wybraniec, Maciej Faryan, B łażej Kusz, Anetta Lasek-Bal, Katarzyna Mizia-Stec Tags: Correspondence Source Type: research

Response to the letter concerning the article "Rivaroxaban in secondary cardiogenic stroke prevention: two-year single-centre experience based on follow-up of 209 patients".
PMID: 27197013 [PubMed - in process]
Source: Polish Heart Journal - May 21, 2016 Category: Cardiology Authors: Lasek-Bal A, Urbanek T, Puz P, Piekarski M Tags: Kardiol Pol Source Type: research

Rivaroxaban in secondary cardiogenic stroke prevention: two-year single-center experience based on follow-up of 209 patients.
CONCLUSIONS: For patients with non-valvular atrial fibrillation and cerebrovascular events , the use of rivaroxaban in a real-world clinical setting results in a high efficacious treatment profile and acceptable safety. PMID: 26502939 [PubMed - as supplied by publisher]
Source: Polish Heart Journal - October 27, 2015 Category: Cardiology Authors: Lasek-Bal A, Urbanek T, Puz P, Piekarski M Tags: Kardiol Pol Source Type: research

New-onset atrial fibrillation in patients with elevated troponin I levels in the acute phase of stroke
Troponin I (TnI) increase in the acute phase of stroke may be due to the presence of acute coronary syndrome (ACS), other medical conditions and/or neurogenic-induced cardiac injury, especially in stroke involving the insula of the right brain hemisphere [1]. In this case, damage to cardiomyocytes is probably due to the rapid release of catecholamines into the bloodstream as a result of sympathoadrenal activation [2,3]. The consequences of cardiac injury may include new-onset arrhythmias, such as multifocal ventricular beats, couplets and unsustained ventricular tachycardia or atrial fibrillation (AF) [3].
Source: International Journal of Cardiology - May 25, 2015 Category: Cardiology Authors: Anetta Lasek-Bal, Zbigniew Gąsior, Teresa Kowalewska-Twardela, Tomasz Urbanek Source Type: research

Pages: 1  2